Статья
Причины и последствия активации симпатической нервной системы при артериальной гипертензии
Обзор посвящен методам оценки симпатической активности у человека и роли симпатической нервной системы в становлении и прогрессировании артериальной гипертензии. Рассматриваются вопросы причин повышения активности симпатической нервной системы при гипертонической болезни и последствия этой активации в отношении поражения органов-мишеней, метаболических нарушений и отдаленного прогноза.
1. Esler M. Sympathetic activity in experimental and human hypertension. In Manda G edc. Handbook of hypertension, Vol. I ". Atnsterdam, Elsevier 1997; 628-73.
2. Julius S. Changing role of the autononomic nen ous system in human hypertension. J. Hypertens 1990; 8: S59-S65·
3. Saab PG, Llabre MM, Ma M et ai. Cardiovascular responsibility to stress in adolescents with and without persistently elevated blood pressure. J Hypertens 2001; 19:21-7.
4. Grossi G, Esler M. How to assess sympathetic activity in humans. I Hvpertens 1999;17:719-34.
5. Sakata K, Shirotani M, Yoshida H, Kurata C. Cardiac sympathetic nervous sys-tem in early essential hypertension assessed bv 1231-M1BG. JNuclearMedicine 1999; 40 (I): 6-І I.
6. Fagret D, Wolf JE, Vanzetto G,Borrel E. Myocardial uptake of metaiodbemsyl-guanidine in patients with left ventricular hypertrophy secondary to valvular aotrtic stenosis. J Nucl Med 1993; 34:57-60.
7. Imamura Y,Ando H, Mitsuoka W. et al. Iodine-123 metajodbensylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure. Am J Coll Cardiol 1995; 26:1594-9.
8. Parati G, Rienzo M, Mancia G. How to assess baroreflex sensitivity: from the cardiovascular laboratory to daily life.J Hypertens 2000; 187-20.
9. Komer PJ, Tomkin AM, Uther JB. Reflex and mechanical circulatory effects of graded Valsalva maneuvers in normal man.J Appl Physiol 1976; 40:434-40.
10. Samueloff SL, Browse NL, Shepherd TJ. Response of capacity vessel in human limbs to head-up tilt and suction on the lower body. J Appl Physiol 1996; 21: 47-54.
11. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res
12. Piekenng TG, Gribbin B, Sleight P. Comparison of the reflex heart rate responses to rising and falling arterial pressure in man. Cardiovasc Res 1972; 6:2 77-83.
13. j. Parati G, Mancia G. The neck chamber technique. G itai Cardiol 1992; 22·. 511-6.
14. Yamada Y, Miyajima E, Tochicubo O et al. Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989; 13:870-7
15. Anderson EA Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertension: evidence from direct intraneural recordings. Hypertension 1989; 14:177-83.
16. Callister R, Suwamo NO, Seals DR. Sympathetic activity is influenced by task difficulty and stress perception during mental challenge in humans. J physiology 1992;454:373-87.
17. Julius S, Krause L, Schork N et al. Hyperkinetik borderline hypertension in Tecumsen, Michigan. JHypertens 1991, 9: 77-84.
18. Jennings GL, Noradrenaline spillover and microneurography in patients with primary hypertension. J Hypertens 1998; 16 (suppl. 3): 35-8.
19. Elser M. The sympathetic system and hypertension. AMJ Hypertens 2000; 13. 99S-105S.
20. Kotchen JM, Kotchen TA, Guthrie GP et al. Correlates of adolescent blood pressure at fife-yearfollow-up. Hypertens 1980; 2:124-9
21. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart study. Am J Hypertens 1995; 8:657-65-
22. Wallin BG, Kunimoto MM, Sellgren J. Possible genetic influence on the strength of human muscle sympathetic nerve activity at rest. Hypertendon 1993; 22: 282-92.
23. Williams PD, Puddey IB, Beilin LJ. Genetic influence on plasma catecholamines in human twins. J Clin Endocrinol metabolism 1993; 84: 225-30.
24. Ferrier C, Cox H, Elser M. Elevated total body Noradrenaline spillover in nor-motensive members of hypertensive families. Clin Sci 1993; 84:225-30.
25. Piccirilo G, Viola E, Nocco M et al. Autonomic modulation of heart rate and blood pressure variability in normotensive offspring of hypertensive subjects J Lab ClinMed 2000; 135:145-52.
26. Elser M, Lambert G, Jennings G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences.J Hypertension 1990; (suppl. 7): S53-S57.
27. Lawler JE, Barker GF, HubbardJW, Schaub RG. Effects of stress on blood pressure and cardiac pathology in rats with borderline hypertension. Hypertension 1981;3:496-05.
28. Koepke JPJones S, DiBona GP. Stress increases renal nerve activity and decreases sodium excretion in Dahl rats. Hypertension 188; 11:334-8.
29. Гротель Д.М. К вопросу об этиопатогенезе гипертонической болезни в Ленинграде в 1942—43 гг. Работы Ленинградских врачей за годы Отечественной войны. Л:Медгиз. 1946; 8:24-48.
30. Poulter NR, Khaw КГ, Hopwood ВЕК et al. The Kenyan Luo Migration Study: observations on the initiation of the rise in blood pressue. Br Med J 1990; 300: 967-72.
31. Mark AL. Thesympathetic nervous system in hypertension: a potential longterm regulator of blood pressure. J Hypertens 1996; 14 (suppl.5): 159-65
32. Folkow B Integration of hypertension research in the era of molecular biology. J Hypertens 1995; 5:18-27
33. TyrolerHA Socioeconomic status in the epidemiology and treatment of hypertension. Hypertension 1989; 13 (suppl.): 194-7
34. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of literature. Circulation 1993; 88:1973-98.
35. SteptoeĄ Cropley M Joekes.Job strain, blood pressure and response to uncontrollable stress.J Hypertens 1999; 17:193-200.
36. Timio M, Verdecchia P, Rononi Met al.Age and blood pressure changes: a 20-year follow-up study of nuns of a selected order. Hypertension 1988; 12:457-61.
37. Karasek RA Job demands, job decision latitude, and mental strain: implications fro job redesign.AdminSci Q 1979; 24:285-307.
38. Schnall PL, Pieper С, Schwartz JE et al. The relationship between job strain, workplace, diastolic blood pressure, and Iefl ventricular mass index.J Am Med Assoc 263:1929-З5.
39. Schnall PL, Schwartz JE, Landsbergis PA et al. Relation between job strain, alcohol, and ambulatory blood pressure. Hypertension 1992; 19:488-94
40. Meredith TT, Frieberg PJennings G et al. Exercise training lowers resting renal but not cardiac sympathetic activity. Hypertension 1991; 18:575-82.
41. Jennings G, Nelson L, NestelP et al. The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986; 73:30-40.
42. Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. QJ Med 1986; 236: 1081-90.
43. Young JB, Landsberg L Supression of the sympathetic nervous system during fasting Science 1977; 196:1473-5.
44. Jung RT, Shetty PS, Barand M et al. Role of catecholamines in hypotensive response to dieting.Br Med J 1979; 1:12-3
45. Julius S, Gundbradsson T, Jamerson K et al. The interconnection between sympathetics, microciroulation, and insulin resistance in hypertension Blood Pressure 1992;1:9-19·
46. Kannel WB, Sortie P. Hypertension in Framingham. In Epidemiology and Control of Hypertension. New York: Stratton; 1975; 553-92.
47. Uaynes WG, Sivitz Wl, Morgan DA et al. Sympathetic and cardiorenal actions of leptin.Hypertension 1997; 30:619-23.
48. Vaz M,Jenings G, Tumer A et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-9.
49. Kassab S, Kato T, Wilkins FC et al. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-7.
50. Grossi G, Seravalle G. Mechanisms responsible for the sympathetic activation by sigarette smoking in hmans. Ciculation 1994; 90:248-53.
51. Gropelli A, Giorgi D, Ombomi S et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10:495-9
52. Gropelli A, Ombomi S, Parati G et al. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alfa-inhibition. J Hypertens 1990; 8: S35-S40.
53. Ferrier CJennings G, Eisenhofer G et al. Evidence of increased noradenaline release from subcortical brain regions in essential hypertension.} Hypertens 1993; U: 1217-27.
54. Rumantir MS, Vaz M, Jennings GL et al. Neural mechanisms in human obesity-related hypertension. J hypertension 1999; 17:1125-33.
55. Squire IB, Reid JL. Interactions between the renin angiotensin system and autonomic nervous system. In Robertson JLS. The Renin Angiotensin System. London: Gouer; 1993.
56. Mangoni AA, Mircoli L, Gianattassio C et αί Effect of sympathectomy on mecbanical properties of common carotid andfemoral arteries. Hypertension 1999; 30:1095-88.
57. Hart M Heistad D, Brody M. Effect of chronic hypertension and sympathetic denenation on wall/lumen ratio of cerebral vessels. Hypertension 1980; 2: 419-28.
58. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertesnion.J Hypertnsion 1991; 9:987-91.
59. Meredith IT, Brougton Ą Jennings G, Elser MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Eng J Med 1991,325:618-24
60. Manolis A Does vasopressin interfere ivith left ventricular hypertrophy? Clin & ExpHypertens 1993; 15:539-55
61. Mann DL, Kent RL, Pearson B et al. Adrenergic effects on the biology of the adult mammalain cardiocyte. Circulation 1992; 85: 790-804·
62. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an adrenergic response. J Clin Invest 1983; 72: 732-8.
63. Simpson PS, Kariya K, Kams LR et al. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem 1991; 104:35-43
64. Mancia AL. Bjom FolkovAward Lecture. The sympathetic nervous system in hypertension. J Hypertension 1997; 15:1553-65-
65. Elser M,Julius S. Zweifler A et al. Mild high-renin essential hypertension: neurologic human hypertension ?N Eng J Med l977; 296:405-11.
66. Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
67. Diebert DC, Defronzo RA. Epinephrine-induced insulin resistance in man.J Clin Invest 1980; 65: 717-21.
68. Zeman RJ, Ludenmann R, Easton TG. Slow to fast alterations in skeletal muscle fibers caused by clebuterol, a beta-2-receptor agonist. Am J Physiol 1968; 254: E726-E732.
69. Julius S. Gudbrensson T.Jetnerson KA. The hemodynamic link between insulin resistance and hypertension (hypothesis).J Hypertension 1991; 9:983-6.
70. Facchini F, Chen Y, Ctinkinbeard C. Insulin resistance, hyperinsulinemia, and dystipidemia in nonobese individuals with a famili history of hypertension. Am J Hypertens 1992; 5:694-9
71. Sacks FM, Dzau VJ.Adrenergic effects on plasma lipoprotein metbabolism Am J Med 1986; 80 (suppl. 2A): 71 -81.
72. Tibblin G, Bergents S, Bjure J et al. Hematocrit, plasma protein, plasma volume and viscosity in eratly hypertensive disease.Am J Heart J 1966; 72:165-76.
73. CirriUo S, Laurensi M, Trevisan M et al. Hematocrit, blood pressure and hypertension. The GubbioPopulation Study. Hypertension 1992; 20:319-26.
74. Julius S, Pascuall AV,Abercbt et al. Effect ofbea-adreergic blockade on plasma volume in human subjects. Proc Sic Exp Biol Med 1972; I40:982-5
75. Kjeldon SE, Gjesdal K, Eide A et al. Incresed beta-thromboglibin in essential hypertension: interactions between arterial plasma adrenaline, plateletjunction and blood lipids. Acta Med Scand 1983; 213:369-73
76. Cocks TM, Angus JA Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983; 305: 62 7-30.
77. Bruck il, Gossl M, Spitthover R et al. The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline indused vasoconstriction: effects of the alfa 2-receptor antagonist yohimbine J Hypertens 2 OO I; 19:907-11.
78. Mosqueda-Carcia R, Inagami T, Applsami M et al. Endotphelin as a neuropeptide. Cardiovascular effects of brainstem of normotensive rats. Circ Res 1993; 72: 20-35.
79. Wenzel RR, Rutherman J, Bruck II et al. Endothelin-I receptor antagonist inhibits angiotensin II and noradrenalin in man. Br J Pharmacol 2001; 52: 151-7.
80. Wenzel RR, Spicker L, Qui S et al. Il-imodasoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension 1998,-32:1022-7.
81. Kim JR, Kiefe CL, Lui K Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension 1999; 33: 64O-6.
82. Palatini PJulius S.Heart rate and cardiovascular risk.J Hypertension 1997; 15:3-17.
83. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113:1489-94
84. Julius S. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.Eur Heart J 1998; 19 (suppl.F): 14-8.
85. Levy RL, White PD, Sroud WD, Hillman CC. Transient tachycardia: prognostic significance alone and in association ivith transient hypertension. JAMA 1945; 129:585-8.
86. Schroll M, Hagerup LM. Risk factors of myocardial infarction and death in men aged 50 at entry. A ten-year prospective study from the Glostrup population studies. Dan Med Bull 1977; 24:252-5.